Answers are grounded in this paper and cite their sources.
THE use of platelet transfusions has been limited by the failure to preserve platelets by conventional storage technics. Preparation of fresh platelet concentrates on a "demand" basis is burdensome for any blood bank that is not involved in supporting a large leukemia service, where there would be constant need for platelet transfusions, permitting integration of the platelet program into the daily routine.A system is available for blood-component separation using whole blood collected in ACD NIH Formula A (ACDA).1 The basic principle of this system involves the addition of ACD B solution to platelet-rich plasma that has been derived from . . .
No takes yet. Share an insight, caveat, or question.
Cohen et al. (1966) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: